Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 6
2010 3
2011 7
2012 4
2013 6
2014 6
2015 6
2016 11
2017 15
2018 15
2019 24
2020 29
2021 32
2022 40
2023 35
2024 22
2025 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
Galli M, Benenati S, Laudani C, Simeone B, Sarto G, Ortega-Paz L, Rocco E, Bernardi M, Spadafora L, D'Amario D, Greco E, Frati G, Federici M, Mehran R, Crea F, Angiolillo DJ, Sciarretta S. Galli M, et al. Among authors: d amario d. J Am Coll Cardiol. 2025 Nov 18;86(20):1805-1819. doi: 10.1016/j.jacc.2025.08.027. Epub 2025 Aug 27. J Am Coll Cardiol. 2025. PMID: 40892610 Free article.
Impact of a personalized, strike early and strong lipid-lowering approach on low-density lipoprotein-cholesterol levels and cardiovascular outcome in patients with acute myocardial infarction.
Patti G, Cumitini L, Bosco M, Marengo A, D'Amario D, Mennuni M, Solli M, Grisafi L. Patti G, et al. Among authors: d amario d. Eur Heart J Cardiovasc Pharmacother. 2025 Mar 13;11(2):143-154. doi: 10.1093/ehjcvp/pvaf004. Eur Heart J Cardiovasc Pharmacother. 2025. PMID: 39855642 Free PMC article.
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study.
Ray KK, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Bardet A, Lamparter M, Chhabra R, Soronen J, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL; SANTORINI Study Investigators. Ray KK, et al. Eur J Prev Cardiol. 2024 Nov 11;31(15):1792-1803. doi: 10.1093/eurjpc/zwae199. Eur J Prev Cardiol. 2024. PMID: 38861400
Bivalirudin in acute coronary syndromes.
Galli M, Bernardi M, Ortega-Paz L, Nerla R, D'Amario D, Franchi F, Biondi-Zoccai G, Angiolillo DJ. Galli M, et al. Among authors: d amario d. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(12):901-911. doi: 10.1080/14779072.2023.2273902. Epub 2023 Dec 13. Expert Rev Cardiovasc Ther. 2023. PMID: 37919937
Sex Differences in Heart Failure.
Savarese G, D'Amario D. Savarese G, et al. Among authors: d amario d. Adv Exp Med Biol. 2018;1065:529-544. doi: 10.1007/978-3-319-77932-4_32. Adv Exp Med Biol. 2018. PMID: 30051405 Review.
The effects of SGLT2i on cardiac metabolism in patients with HFpEF: Fact or fiction?
Cinti F, Laborante R, Cappannoli L, Morciano C, Gugliandolo S, Pontecorvi A, Burzotta F, Donniacuo M, Cappetta D, Patti G, Giaccari A, D'Amario D. Cinti F, et al. Among authors: d amario d. Cardiovasc Diabetol. 2025 May 14;24(1):208. doi: 10.1186/s12933-025-02767-9. Cardiovasc Diabetol. 2025. PMID: 40369599 Free PMC article. Review.
Effects of sacubitril-valsartan on aging-related cardiac dysfunction.
Telesca M, De Angelis A, Donniacuo M, Bellocchio G, Riemma MA, Mele E, Canonico F, Cianflone E, Torella D, D'Amario D, Patti G, Liantonio A, Imbrici P, De Luca A, Castaldo G, Rossi F, Cappetta D, Urbanek K, Berrino L. Telesca M, et al. Among authors: d amario d. Eur J Pharmacol. 2024 Sep 5;978:176794. doi: 10.1016/j.ejphar.2024.176794. Epub 2024 Jul 3. Eur J Pharmacol. 2024. PMID: 38968980 Free article.
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report.
Leccisotti L, Cinti F, Sorice GP, D'Amario D, Lorusso M, Guzzardi MA, Mezza T, Gugliandolo S, Cocchi C, Capece U, Indovina L, Ferraro PM, Iozzo P, Crea F, Giordano A, Giaccari A. Leccisotti L, et al. Among authors: d amario d. Cardiovasc Diabetol. 2022 Sep 3;21(1):173. doi: 10.1186/s12933-022-01607-4. Cardiovasc Diabetol. 2022. PMID: 36057768 Free PMC article. Clinical Trial.
251 results